1. Home
  2. QURE vs CVLG Comparison

QURE vs CVLG Comparison

Compare QURE & CVLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QURE
  • CVLG
  • Stock Information
  • Founded
  • QURE 1998
  • CVLG 1986
  • Country
  • QURE Netherlands
  • CVLG United States
  • Employees
  • QURE N/A
  • CVLG N/A
  • Industry
  • QURE Biotechnology: Pharmaceutical Preparations
  • CVLG Trucking Freight/Courier Services
  • Sector
  • QURE Health Care
  • CVLG Industrials
  • Exchange
  • QURE Nasdaq
  • CVLG Nasdaq
  • Market Cap
  • QURE 860.8M
  • CVLG 718.4M
  • IPO Year
  • QURE 2007
  • CVLG 1994
  • Fundamental
  • Price
  • QURE $15.18
  • CVLG $28.30
  • Analyst Decision
  • QURE Strong Buy
  • CVLG Strong Buy
  • Analyst Count
  • QURE 8
  • CVLG 2
  • Target Price
  • QURE $33.00
  • CVLG $34.75
  • AVG Volume (30 Days)
  • QURE 1.2M
  • CVLG 92.3K
  • Earning Date
  • QURE 02-26-2025
  • CVLG 01-23-2025
  • Dividend Yield
  • QURE N/A
  • CVLG 1.19%
  • EPS Growth
  • QURE N/A
  • CVLG N/A
  • EPS
  • QURE N/A
  • CVLG 1.51
  • Revenue
  • QURE $28,587,000.00
  • CVLG $1,128,130,000.00
  • Revenue This Year
  • QURE $153.92
  • CVLG $5.29
  • Revenue Next Year
  • QURE N/A
  • CVLG $6.37
  • P/E Ratio
  • QURE N/A
  • CVLG $18.39
  • Revenue Growth
  • QURE N/A
  • CVLG 0.22
  • 52 Week Low
  • QURE $3.73
  • CVLG $21.52
  • 52 Week High
  • QURE $19.18
  • CVLG $30.77
  • Technical
  • Relative Strength Index (RSI)
  • QURE 52.73
  • CVLG 51.25
  • Support Level
  • QURE $13.70
  • CVLG $27.56
  • Resistance Level
  • QURE $15.18
  • CVLG $28.25
  • Average True Range (ATR)
  • QURE 1.07
  • CVLG 0.68
  • MACD
  • QURE -0.54
  • CVLG 0.12
  • Stochastic Oscillator
  • QURE 29.76
  • CVLG 74.79

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

About CVLG Covenant Logistics Group Inc.

Covenant Logistics Group Inc together with its wholly-owned subsidiaries offers truckload transportation and freight brokerage services to customers throughout the continental United States. The company's reportable segments include Expedited, Dedicated Services, Managed Freight and Warehousing. Expedited segment provides truckload services to customers with high service freight and delivery standards. Dedicated segment provides customers with committed truckload capacity over contracted periods with the goal of three to five years in length. Managed Freight segment includes brokerage services and TMS. Warehousing segment provides day-to-day warehouse management services to customers who have chosen to outsource this function. Majority of revenue is generated from expedited segment.

Share on Social Networks: